Efficacy of sirolimus-based, steroid avoidance maintenance immunosuppression in Black de novo kidney transplant recipients.
Phase of Trial: Phase II/III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Sirolimus (Primary) ; Antithymocyte globulin; Ciclosporin; Corticosteroids
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 20 Feb 2017 Status changed from active, no longer recruiting to completed.
- 09 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Nov 2005 New trial record.